First phase II results of cisplatin/epinephrine in primary liver cancer.
D000970:Antineoplastic Agents / Q000008:administration & dosage*; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D002945:Cisplatin / Q000008:administration & dosage*; D017322:Clinical Trials, Phase II as Topic; D004338:Drug Combinations; D004837:Epinephrine / Q000008:administration & dosage*; D006801:Humans; D015552:Injections, Intralesional; D008113:Liver Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents; D004338:Drug Combinations; D002945:Cisplatin; D004837:Epinephrine